A large-scale genome study uncovered IL31 as a key genetic contributor to prurigo nodularis, linking it to immune-regulatory ...

Prurigo nodularis is an inflammatory skin condition that causes the development of intensely itchy skin and bumps or lumps (nodules) on the legs, arms, upper back, or abdomen. This article ...

Prurigo nodularis is an extremely itchy skin condition. It causes a rash that often includes hard lumps called nodules. You might also hear it called nodular prurigo. Doctors don’t know exactly ...

Prurigo nodularis (PN) is an inflammatory skin condition marked by firm, itchy, often painful bumps (nodules) on the skin. Read on for more on causes and treatments.

Prurigo nodularis (PN) is challenging to treat, but new treatments show promise. Let’s look at symptoms and lots of ways to manage PN.

Despite the approval of dupilumab (Dupixent) in September 2022, there is an ongoing dearth of clinically effective treatments for prurigo nodularis, prompting the present investigation of the ...

Abrocitinib may be an effective and well-tolerated treatment for adults with prurigo nodularis and chronic pruritus of unknown origins, according to a study.

NEW ORLEANS — Symptoms of prurigo nodularis were significantly improved after 16 weeks of monotherapy with nemolizumab, according to a presenter at the American Academy of Dermatology Annual ...

Subjects in the trial saw clearance or near-clearance of skin nodules, as measured by the Investigator’s Global Assessment score.

Co-moderator Joel Gelfand, MD, of the University of Pennsylvania in Philadelphia, asked whether the medication is "getting where it needs to be" in patients with thick prurigo nodules.

A dermatologist discusses nemolizumab (Nemluvio). Get the facts on this new treatment for prurigo nodularis: how well it works and who might benefit.